Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia

American Journal of Human Genetics

Volumn 61, Issue 1, 1997, Pages 68-79

  Shovlin, Claire L ^a,c,e   Hughes, J M B ^c   Scott, J ^c   Seidman, Christine E ^b   Seidman, J G ^a,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENDOGLIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; RNA SPLICING;

EID: 0030860380     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/513906     Document Type: Article

References (36)

1. Belgrader P, Maquat LE (1994) Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutation can facilitate exon skipping. Mol Cell Biol 14: 6326-6336
2. Bellon T, Corbi A, Lastres P, Cales C, Cebrian M, Vera S, Cheifetz S, et al (1993) Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic domains. Eur J Immunol 23:2340-2345
3. Berg JN, Guttmacher AE, Marchuk DA, Porteous MEM (1996) Clinical heterogeneity in hereditary haemorrhagic telangiectasia - are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33:256-257
4. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95: 422-427
5. Braverman IM, Keh-Yen A (1983) Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol 81:489-497
6. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267:19027-19030
7. Chilvers ER, Whyte MKB, Jackson JE, Allison DJ, Hughes JMB (1990) Effect of percutaneous catheter embolisation on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Med 142:420-425
8. Clark ER, Clark EL (1940) Microscopic observations on the extra-endothelial cells of living mammalian blood vessels. Am J Anat 66:2-49
9. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoeisis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121:1845-1854
10. Edwards A, Civitello A, Hammond HA, Caskey CT (1991) DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet 49:746-756
11. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361-8364
12. Guttmacher AE, Marchuk DA, White RI (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924
13. Hecker KH, Roux KH (1996) High and low annealing temperatures increase both specificity and yield in touchdown and step-down PCR. BioTechniques 20:478-485
14. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marodel I, Yoon S-J, Stenzel TT, et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 13:189-195
15. Kaartinen V, Voncken JW, Schuler C, Warburton D, Bu D, Heisterkamp N, Groffen J (1995) Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11: 415-421
16. Koh GY, Kim S-J, Klug MG, Park K, Soonpaa MH, Field LJ (1995) Targeted expression of transforming growth factor-β1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 95:114-121
17. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, et al (1996) Endoglin modulates cellular responses to TGF-β1. J Cell Biol 133:1109-1121
18. Laviguer A, La Branche H, Kornblihtt AR, Chabot B (1993) A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 7:2405-2417
19. Madri JA, Merwin JR, Bell L, Basson CT, Kocher O, Perlmutter R, Prinz C (1992) Interactions of matrix components and soluble factors in vascular responses to injury. In: Simionescu N, Simionescu M (eds) Endothelial cell dysfunctions. Plenum Press, New York
20. Manley JL, Tacke R (1996) SR proteins and splicing control. Genes Dev 10:1569-1579
21. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, et al (1995) Six novel endoglin mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type I suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983-1985
22. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, et al (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351
23. Piantanida M, Buscarini E, Dellavecchia C, Minelli A, Rossi A, Buscarini L, Danesino C (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33:441-443
24. Plauchu H, de Chadarévian JP, Bideau A, Robert JH (1989) Age-related profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291-297
25. Puffenberger EG, Francomano CA (1991) PCR-based detection of polymorphic DdeI and KpnI sites in intron 5 of the adenylate kinase (AK1) gene. Nucleic Acids Res 19:1161
26. Rendu H (1896) Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muquez. Gaz Hop (Paris) 135: 132-133
27. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, et al (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
28. Shovlin CL (1996) A streamlined method for screening a P1 library. BioTechniques 21:388-390
29. Shovlin CL, Hughes JMB, Tuddenham EGD, Temperley I, Perembelon YFN, Scott J, Seidman CE, et al (1994a) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205-209
30. Shovlin CL, Kwiatkowski DJ, Hughes JMB, Seidman CE, Seidman JG (1995a) Mapping in the D9S59-67 interval on human chromosome 9. Ann Hum Genet 59:381-382
31. Shovlin CL, Scott J (1996) Inherited diseases of the vasculature. Annu Rev Physiol 58:483-507
32. Shovlin CL, Simmonds HA, Fairbanks LD, Deacock SJ, Lechler RI, Hughes JMB, Webster ADB, et al (1994b) Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J Immunol 153:2331-2335
33. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JMB (1995b) Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Q J Med 88:879-887
34. Yamashita H, Ichijoro H, Grimsby S, Moren A, ten Dijke P, Miyazono K (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem 269:1995-2001
35. Zhang H, Shaw ARE, Mak A, Letarte M (1996) Endoglin is a component of the transforming growth factor (TGF)-β receptor complex of human pre-B leukemic cells. J Immunol 56:565-573
36. Zhang S, Ruiz-Echevarria MJ, Quan Y, Peltz SW (1995) Identification and characterization of a sequence motif involved in nonsense-mediated mRNA decay. Mol Cell Biol 15: 2231-2244